A patient who developed urticaria and pruritus after possible exposure to a surgical drape, glue, or cleaner on Thursday and is scheduled for allergy immunotherapy (allergy shots) tomorrow, can he take a single 100 mg dose of diphenhydramine (Benadryl) for relief?

Can This Patient Take 100 mg of Benadryl Before Immunotherapy Tomorrow?

No, this patient should not take 100 mg of diphenhydramine (Benadryl) before allergy immunotherapy tomorrow. The standard adult dose is 25–50 mg, not 100 mg, and taking antihistamines before immunotherapy creates a critical safety concern by potentially masking early warning signs of a systemic allergic reaction 1.

---

Why 100 mg Is Not the Appropriate Dose

• The standard therapeutic dose of oral diphenhydramine for allergic symptoms is 25–50 mg, with a duration of effect of 4–6 hours 1.
• A 100 mg single dose exceeds the recommended range and increases the risk of excessive sedation, hypotension, dizziness, blurred vision, dry mouth, urinary retention, and anticholinergic toxicity 1.
• FDA-approved oral formulations contain 12.5 mg per 5 mL or 25 mg per 10 mL, making 100 mg an unusually high single dose that is not standard practice 2.

---

The Critical Safety Issue: Antihistamines Before Immunotherapy

Masking Early Reactions

• There is significant concern that antihistamines taken before each immunotherapy injection might mask a minor reaction that would otherwise alert the physician to an impending systemic reaction 1.
• While one randomized controlled study showed that premedication with antihistamines reduced the frequency of severe systemic reactions during conventional immunotherapy, the guidelines emphasize that patients might still have life-threatening anaphylaxis despite premedication 1.
• The concern is that diphenhydramine could delay the onset of a systemic reaction beyond the standard 30-minute waiting period when the patient is under physician supervision, thereby increasing risk 1.

When Premedication Is Appropriate

• Premedication with antihistamines is recommended specifically for cluster and rush immunotherapy protocols (accelerated schedules), not for standard weekly immunotherapy 1.
• For cluster immunotherapy, premedication with a nonsedating antihistamine (such as loratadine) 2 hours before the first injection reduced both the number and severity of systemic reactions 1.
• For rush immunotherapy with inhalant allergens, premedication with a 3-day course of prednisone plus H1 and H2 antihistamines reduced systemic reaction rates from 73% to 27% 1.
• Because the risk of systemic reactions from rush venom immunotherapy is relatively low, routine premedication before rush venom immunotherapy is usually unnecessary 1.

Consistency in Practice

• Because many patients take an antihistamine as part of their overall allergy management, it is important to determine whether they have taken it on the day they receive an immunotherapy injection 1.
• For consistency in interpretation of reactions, it is desirable that patients consistently either take their antihistamine or avoid it on days when they receive immunotherapy—not switch back and forth 1.

---

Treating the Current Urticaria and Pruritus

First-Line Treatment for Urticaria

• The international guideline for urticaria recommends starting with a standard dose of a second-generation H1-antihistamine (such as cetirizine, loratadine, or fexofenadine) as first-line treatment 1, 3, 4, 5.
• Second-generation antihistamines are preferred over first-generation antihistamines (like diphenhydramine) because they cause less sedation, have fewer anticholinergic side effects, and do not impair cognitive function or quality of life 1, 3, 4, 5.
• If symptoms are intolerable or inadequately controlled after 2–4 weeks, the dose of the second-generation antihistamine can be increased up to 4-fold the standard dose 1, 3.

Role of Diphenhydramine in Urticaria

• Diphenhydramine has been used historically for treatment of urticaria and provides prompt relief of pruritus in many patients 6, 7.
• For acute allergic reactions with pruritus, diphenhydramine (50 mg IV) is more effective than cimetidine alone, though the combination of diphenhydramine plus cimetidine is more effective for urticaria than diphenhydramine alone 7.
• However, diphenhydramine causes significant sedation, anticholinergic side effects (dry mouth, urinary retention, blurred vision, constipation), and increased risk of delirium—especially in older adults 1, 8, 9, 10.
• The American Geriatrics Society warns that diphenhydramine increases the risk of delirium by approximately 1.7-fold in older adults and should be avoided in this population 8, 9.

Practical Approach for This Patient

• For the current urticaria and pruritus from the surgical exposure, start a second-generation antihistamine (e.g., cetirizine 10 mg daily, loratadine 10 mg daily, or fexofenadine 180 mg daily) rather than diphenhydramine 1, 3, 4, 5.
• If symptoms are severe and intolerable, the dose can be increased up to 4-fold (e.g., cetirizine 40 mg daily in divided doses) or a short course of oral corticosteroids can be considered 1, 3.
• Avoid triggers such as hot water, tight clothing, and NSAIDs, which can exacerbate urticaria 4.
• If diphenhydramine is absolutely necessary for severe pruritus tonight, use the standard dose of 25–50 mg, not 100 mg, and take it well before bedtime to allow sedation to wear off by morning 1, 2.

---

Timing Considerations for Tomorrow's Immunotherapy

Standard Waiting Period and Reaction Monitoring

• Patients receiving allergen immunotherapy should remain under physician supervision for at least 30 minutes after each injection, as almost all severe systemic reactions begin within 30 minutes 1.
• Late systemic reactions (occurring 35 minutes to 6 hours after injection) account for 38% of all systemic reactions, with extracts containing only pollen antigens more commonly associated with both immediate and late reactions 11.
• Patients receiving rush or cluster immunotherapy should remain under supervision for a longer period (1.5–3 hours) due to the increased risk of delayed reactions 1.

Risk Factors for Systemic Reactions

• Risk factors for systemic reactions during immunotherapy include symptomatic asthma, injections during periods of symptom exacerbation, high degree of hypersensitivity, use of beta-blockers, injections from new vials, and dosing errors 1.
• Immunotherapy administered during periods when the patient is exposed to increased levels of allergen to which they are sensitive might be associated with an increased risk of systemic reaction, especially if the patient is experiencing significant exacerbation of symptoms 1.
• Patients at high risk of systemic reactions should, where possible, receive immunotherapy in the office of the physician who prepared the allergen extract, with appropriately trained personnel and resuscitative equipment available 1.

Decision Algorithm for This Patient

1. Assess current symptom severity: Is the urticaria/pruritus well-controlled with second-generation antihistamines, or is it severe and ongoing?
2. Evaluate asthma status: Does the patient have asthma? If yes, is it well-controlled (FEV1 >80% predicted)? Poorly controlled asthma is a significant risk factor for systemic reactions 1.
3. Consider delaying immunotherapy: If the patient has active, symptomatic urticaria or poorly controlled asthma, consider postponing the immunotherapy injection until symptoms are better controlled 1.
4. If proceeding with immunotherapy tomorrow:
   • Do not take diphenhydramine the morning of the injection to avoid masking early warning signs of a reaction 1.
   • Continue the second-generation antihistamine consistently (either take it every day including injection days, or avoid it every day including injection days—do not switch) 1.
   • Ensure the patient waits the full 30 minutes (or longer if on a rush/cluster protocol) after the injection 1.
   • Inform the immunotherapy staff about the recent allergic reaction so they can monitor closely and consider dose adjustment if needed 1.

---

Common Pitfalls to Avoid

• Do not use 100 mg of diphenhydramine as a single dose—this exceeds standard dosing and increases toxicity risk without additional benefit 1, 2.
• Do not take diphenhydramine immediately before immunotherapy unless specifically instructed by the allergist as part of a premedication protocol for rush or cluster immunotherapy 1.
• Do not assume that premedication with antihistamines eliminates the risk of anaphylaxis—life-threatening reactions can still occur despite premedication 1.
• Do not proceed with immunotherapy if the patient has active, symptomatic asthma or significant allergic symptoms—this increases the risk of systemic reactions 1.
• Do not use diphenhydramine in elderly patients, those with glaucoma, benign prostatic hyperplasia, urinary retention, dementia, or cognitive impairment due to increased risk of delirium and anticholinergic toxicity 8, 9, 10.